Wein Matthew bought MGX
April 1, 2026 · Form 4 insider transaction
Wein Matthew bought 11,000 shares of Metagenomi Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
11,000
Price
$0.00
Total value
N/A
InsiderWein Matthew
RoleOfficer
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateApril 1, 2026
Filing dateApril 3, 2026
Shares owned after125,549
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
These shares represent restricted stock units ("RSUs"). 25% of the RSUs shall vest on June 5, 2027, with the remainder vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service with the Issuer on each such vesting date.